Safety and efficacy of the 2.25-mm sirolimus-eluting Bx Velocity stent in the treatment of patients with de novo native coronary artery lesions: the SIRIUS 2.25 trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples